FluroTech Ltd. FLRLF

Company Overview

FluroTech Ltd. (OTC: FLRLF) is a Canada-based technology company focused on analytical testing and data-driven measurement systems, primarily using fluorescence spectroscopy and related sensing technologies. Public disclosures and historical investor materials describe the company as developing portable and rapid-testing platforms intended for industries such as cannabis, agriculture, food safety, and industrial quality assurance. The company’s core value proposition has centered on providing faster and lower-cost alternatives to traditional laboratory testing methods.

Historically, FluroTech evolved from a spectroscopy and fluorescence technology developer into a company targeting commercial applications for cannabis potency analysis and compositional testing. Public filings and corporate materials indicate that its flagship initiatives included portable testing solutions designed to reduce turnaround time for producers and processors. Available public information suggests the company has operated as a small-cap technology issuer with a commercialization-oriented strategy, although some operational details and current commercialization status are difficult to verify consistently across recent public sources. Data inconclusive based on available public sources.

Business Operations

FluroTech’s operations have historically been organized around the development and commercialization of proprietary fluorescence spectroscopy technologies and analytical software platforms. Public filings indicate the company pursued revenue opportunities through hardware systems, software analytics, intellectual property licensing, and strategic commercialization partnerships. Its primary focus appeared to be cannabis testing applications, including potency and quality analysis tools intended for licensed producers and processors.

The company’s operational footprint has primarily been centered in Canada, with efforts directed toward broader North American market opportunities. Public disclosures reference internally developed analytical technologies and intellectual property associated with spectroscopy-based measurement systems. Available records do not clearly confirm the existence of large-scale operating subsidiaries or extensive international joint ventures. Data regarding material long-term commercial partnerships, sustained recurring revenue streams, or major global operating assets remains inconclusive based on available public sources.

Strategic Position & Investments

FluroTech’s strategic direction has historically emphasized rapid analytical testing technologies designed to compete with slower conventional laboratory methods. Corporate communications and investor-facing materials have highlighted goals related to automation, portability, and cost reduction in chemical and compositional analysis. The company has also referenced opportunities involving machine learning-assisted analytics and data interpretation within spectroscopy applications.

Publicly available information indicates that FluroTech pursued commercialization initiatives in the regulated cannabis sector, particularly where producers required faster in-house testing capabilities. The company has also explored adjacent applications in food and agricultural testing markets. However, publicly verifiable information regarding major acquisitions, large-scale institutional investments, or substantial portfolio holdings remains limited. Data inconclusive based on available public sources.

Geographic Footprint

FluroTech has primarily operated from Calgary, Alberta, Canada, which has served as its reported corporate headquarters in public filings and historical company disclosures. The company’s market focus has largely been concentrated in Canada and the broader North American cannabis and analytical testing industries.

While the company has referenced broader commercial opportunities beyond Canada, publicly verifiable evidence of a significant operating presence across Europe, Asia-Pacific, or Latin America is limited. Its international footprint appears to have been primarily commercial and strategic rather than asset-intensive or operationally expansive. Data inconclusive based on available public sources.

Leadership & Governance

FluroTech has historically been governed through a traditional public-company structure with executive leadership overseeing technology commercialization, product development, and investor relations. Public filings and historical disclosures identify several executives and directors associated with the company during various reporting periods, though leadership composition may have changed over time.

Key executives identified in public filings and historical disclosures include:

• Madhukar Choudhary – Chief Executive Officer
• Ross Haghighat – Executive Chairman
• Isobel Mackenzie – Chief Financial Officer
• Kal Malhi – Director

Corporate strategy described in public materials emphasized innovation in rapid-testing technologies, commercialization of proprietary analytical systems, and expansion into regulated industrial testing markets. Due to limited recent disclosures and inconsistent updates across public sources, some governance and executive information may no longer reflect the company’s current organizational structure.